Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma

VTE developed in 11% of lymphoma patients after CAR T-cell therapy and was managed safely with anticoagulation. Coagulation abnormalities after CAR T-cell therapy occur but do not commonly lead to bleeding events.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Hashmi, Hamza, Mirza, Abu-Sayeef, Darwin, Alicia, Logothetis, Constantine, Garcia, Franco, Kommalapati, Anuhya, Mhaskar, Rahul S., Bachmeier, Christina, Chavez, Julio C., Shah, Bijal, Pinilla-Ibarz, Javier, Khimani, Farhad, Lazaryan, Aleksandr, Liu, Hien, Davila, Marco L., Locke, Frederick L., Nishihori, Taiga, Jain, Michael D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2020
Konular:
Stimulus Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479945/
https://ncbi.nlm.nih.gov/pubmed/32877523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002060
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller